The following videos, presented by Medscape Oncology, are designed for healthcare practitioners to earn continuing education (CE) credits.

In this CE program, nurses from the IMF's Nurse Leadership Board (NLB) present new drugs, regimens, and strategies for multiple myeloma.


To Earn These CE Credits

1. Register for free at

2. Login to your Medscape account.

3. Select the course sections below.

4. View this virtual course in its entirety.

5. Complete 1.50 ANCC Contact Hour(s) credit activities.

Note: These CE credits are valid through December 30, 2022.

Image Left
IMF Nurse Leadership Board presents new CE credit for myeloma nurses.
New Drugs, Regimens, and Strategies for Multiple Myeloma: Case Studies for Nurses

IMF Nurse Leadership Board nurses Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN (Taussig Cancer Institute—Cleveland, Ohio), Donna D. Catamero, ANP-BC, OCN, CCRC (The Mount Sinai Health System—New York, NY), and Kim Noonan, DNP, RN, ANP-BC, AOCN® (Dana-Farber Cancer Institute—Boston, MA) discuss new drugs, regimens, and strategies for multiple myeloma. 

Upon completion of this activity, participants should be better able to: 

Discuss treatment regimens for patients with newly diagnosed or relapsed multiple myeloma including appropriate symptom management and patient education
Identify healthcare disparities faced by patients with multiple myeloma who are part of minority groups and strategies to overcome these
Describe strategies to support the patient’s input in therapeutic decisions

Image Left

Supported by independent grants from:

The Annenberg Center for Health Sciences at Eisenhower and International Myeloma Foundation 

Amgen, Abbvie, Bristol Myers Squibb, Janssen Biotech, Karyopharm Therapeutics, Pfizer, GSK, and Takeda Pharmaceuticals

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.